Single domain antibodies that neutralize SARS-CoV-2

15 April 2020 → 14 January 2021
Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Infectious diseases
    • Virology
  • Engineering and technology
    • Medical molecular engineering of nucleic acids and proteins
Coronavirus antibody virus neutralization
Project description

The aim of this project is to isolate single domain antibodies that are directed against the receptor-binding domain that is part of the spike protein of SARS-CoV-2. Those single-domain antibodies, separately and combined, will be evaluated for their capacity to neutralize SARS-CoV-2.